Alixia
Winter 2022 · Active
Targeting the Tumor Ecosystem to address cancer drug resistance.
Location: San Francisco, US
Founded: 2022
Team size: 2
About
Our compounds disrupt the metabolic and
inflammatory triggers in both cancer and quasi-cancerous
cells in the tumor microenvironment. By impacting multiple cell
types, we are enabling effective, lasting cancer treatments.
Founders
Olof MollstedtFounder
Helen ChenFounder
Cancer & aging researcher | entrepreneur| mentor |